SynthesisFrontiers in oncology2026
Risk factors associated with postoperative lymphocele in patients with gynecological malignant tumors: a systematic review and meta-analysis.
Synthesis in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pelvic lymphoceles are a common complication after lymph node dissection for gynecological malignancies, with severe cases leading to significant morbidity and delays in adjuvant therapy. This meta-analysis aims to identify risk factors for postoperative lymphoceles and provide evidence for clinical prevention and management. Methods: A systematic search was performed across eight databases (CNKI, Wanfang, VIP, CBM, Web of Science, PubMed, Cochrane Library, Embase) from inception to August 15, 2025, to include cohort and case-control studies. Two investigators independently screened studies and extracted data. Methodological quality was assessed using the Newcastle-Ottawa Scale, and statistical analyses were conducted with STATA 18.0. Meta-analysis employed fixed- or random-effects models, with heterogeneity evaluated by the I² statistic. The study was registered in PROSPERO (CRD420251053680). Results: 64 studies involving 15,739 patients were included. The pooled incidence of postoperative lymphocele was 30.18%. Moderate to high between-study heterogeneity was detected for most outcomes. Key significant risk factors were as follows: age >50 years (OR = 1.21, 95%CI: 1.02-1.42), BMI ≥24 kg/m² (OR = 1.45, 95%CI: 1.10-1.93), diabetes mellitus (OR = 1.30, 95%CI: 1.11-1.52), laparotomy (OR = 2.76, 95%CI: 2.12-3.58), resection of >20 lymph nodes (OR = 2.75, 95%CI: 2.16-3.51), pelvic and para-aortic lymphadenectomy (OR = 1.86, 95%CI: 1.42-2.43), omentectomy (OR = 1.56, 95%CI: 1.18-2.07), retroperitoneal closure (OR = 2.44, 95%CI: 1.67-3.57), monopolar electrosurgery (OR = 2.48, 95%CI: 1.75-3.51), prolonged operation time (>3h) (OR = 1.56, 95%CI: 1.10-2.21), 24h drainage >100 ml (OR = 1.61, 95%CI: 1.10-2.36), prolonged drainage (>3d) (OR = 1.60, 95%CI: 1.03-2.46), transvaginal drainage (OR = 2.90, 95%CI: 1.92-4.40), ovarian cancer (OR = 1.69, 95%CI: 1.21-2.36), lymphovascular invasion (OR = 1.25, 95%CI: 1.03-1.52), deep myometrial invasion (OR = 1.89, 95%CI: 1.25-2.87), lymph node positivity (OR = 1.59, 95%CI: 1.26-2.00), anemia (OR = 1.20, 95%CI: 1.02-1.40), hypoalbuminemia (OR = 1.58, 95%CI: 1.07-2.34), postoperative chemotherapy (OR = 1.85, 95%CI: 1.29-2.65), and concurrent chemoradiotherapy (OR = 2.49, 95%CI: 1.68-3.69). Advanced FIGO stage was also significant. Conclusions: Clinicians can stratify lymphocele risk by integrating preoperative features, surgical procedures, tumor pathology, nutritional status, and adjuvant therapy to guide individualized management. Intraoperatively, rational planning, limited lymphadenectomy, retroperitoneal preservation, and standardized use of energy devices are recommended. Postoperatively, optimized drainage and correction of nutritional disorders reduce lymphocele risk. Given heterogeneity in some risk factors and predominance of single-center retrospective studies, well-designed prospective studies with unified criteria are needed to validate and refine prevention strategies. Systematic review registration: https://www.crd.york.ac.uk/prospero/, identifier PROSPERO (CRD420251053680).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.